Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013984021> ?p ?o ?g. }
- W2013984021 endingPage "289" @default.
- W2013984021 startingPage "275" @default.
- W2013984021 abstract "The landscape of prostate cancer treatment is rapidly changing as extensive research into potential therapies yields new options. In this article, the literature is reviewed to identify emerging therapies for advanced prostate cancer. Emphasis is placed on agents that have been approved in the United States of America (USA) and the European Union, or that have reached phase III clinical studies. Several new therapies have been approved in recent years across different stages of the natural history of the disease. Degarelix, a luteinizing hormone-releasing hormone antagonist, has been approved for reducing testosterone to castrate levels in hormone-sensitive disease. No new agents have been approved for use in combination with docetaxel chemotherapy, the current standard of care for metastatic castration-resistant prostate cancer. One immunotherapy, sipuleucel-T, has been approved (USA only) in the pre-docetaxel setting. Cabazitaxel, a next-generation taxane, and abiraterone acetate, an inhibitor of androgen biosynthesis, have both been approved as second-line agents following chemotherapy. Enzalutamide (MDV3100), an androgen receptor antagonist, has been shown to increase overall survival in the post-chemotherapy setting in metastatic disease. Denosumab, an antibody-based bone-targeted agent, has been approved for the prevention of skeletal-related events in patients with bone metastases. Radium-223 chloride, an α-emitting radiopharmaceutical, is likely to gain approval soon following promising results in a phase III trial. Clinical studies involving other promising agents are ongoing. The emergence of these therapies adds to the growing armamentarium against prostate cancer." @default.
- W2013984021 created "2016-06-24" @default.
- W2013984021 creator A5047019507 @default.
- W2013984021 date "2013-05-01" @default.
- W2013984021 modified "2023-10-03" @default.
- W2013984021 title "Progress in emerging therapies for advanced prostate cancer" @default.
- W2013984021 cites W1495623746 @default.
- W2013984021 cites W1854708637 @default.
- W2013984021 cites W1896987049 @default.
- W2013984021 cites W1918406592 @default.
- W2013984021 cites W1926992252 @default.
- W2013984021 cites W1968306692 @default.
- W2013984021 cites W1974892500 @default.
- W2013984021 cites W1975448482 @default.
- W2013984021 cites W1981302738 @default.
- W2013984021 cites W1981453652 @default.
- W2013984021 cites W1983225862 @default.
- W2013984021 cites W1984673297 @default.
- W2013984021 cites W1991355732 @default.
- W2013984021 cites W1992053982 @default.
- W2013984021 cites W2002094338 @default.
- W2013984021 cites W2006498539 @default.
- W2013984021 cites W2011155558 @default.
- W2013984021 cites W2019607817 @default.
- W2013984021 cites W2023288243 @default.
- W2013984021 cites W2023366046 @default.
- W2013984021 cites W2026707626 @default.
- W2013984021 cites W2028387248 @default.
- W2013984021 cites W2043859884 @default.
- W2013984021 cites W2049161486 @default.
- W2013984021 cites W2051410494 @default.
- W2013984021 cites W2052234350 @default.
- W2013984021 cites W2065016129 @default.
- W2013984021 cites W2068744546 @default.
- W2013984021 cites W2080439368 @default.
- W2013984021 cites W2099050005 @default.
- W2013984021 cites W2102996930 @default.
- W2013984021 cites W2103059478 @default.
- W2013984021 cites W2103959341 @default.
- W2013984021 cites W2104923745 @default.
- W2013984021 cites W2107142702 @default.
- W2013984021 cites W2108248718 @default.
- W2013984021 cites W2110534364 @default.
- W2013984021 cites W2110707581 @default.
- W2013984021 cites W2115962082 @default.
- W2013984021 cites W2119504728 @default.
- W2013984021 cites W2120292596 @default.
- W2013984021 cites W2120974167 @default.
- W2013984021 cites W2123526148 @default.
- W2013984021 cites W2130803372 @default.
- W2013984021 cites W2132762992 @default.
- W2013984021 cites W2139232028 @default.
- W2013984021 cites W2139695668 @default.
- W2013984021 cites W2139860898 @default.
- W2013984021 cites W2141203222 @default.
- W2013984021 cites W2144769242 @default.
- W2013984021 cites W2149218924 @default.
- W2013984021 cites W2149752186 @default.
- W2013984021 cites W2151063703 @default.
- W2013984021 cites W2155162800 @default.
- W2013984021 cites W2155846302 @default.
- W2013984021 cites W2156659229 @default.
- W2013984021 cites W2161962336 @default.
- W2013984021 cites W2164828052 @default.
- W2013984021 cites W2165088640 @default.
- W2013984021 cites W2165782799 @default.
- W2013984021 cites W2166899077 @default.
- W2013984021 cites W2169258216 @default.
- W2013984021 cites W2227075123 @default.
- W2013984021 cites W2236157811 @default.
- W2013984021 cites W2244473630 @default.
- W2013984021 cites W2249443550 @default.
- W2013984021 cites W2249955518 @default.
- W2013984021 cites W2260909707 @default.
- W2013984021 cites W2278345104 @default.
- W2013984021 cites W2589132608 @default.
- W2013984021 cites W2591013626 @default.
- W2013984021 cites W2607028219 @default.
- W2013984021 cites W2985905496 @default.
- W2013984021 cites W4233890944 @default.
- W2013984021 cites W4235892574 @default.
- W2013984021 cites W4241848697 @default.
- W2013984021 cites W4247786662 @default.
- W2013984021 cites W4254701901 @default.
- W2013984021 doi "https://doi.org/10.1016/j.ctrv.2012.09.005" @default.
- W2013984021 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23107383" @default.
- W2013984021 hasPublicationYear "2013" @default.
- W2013984021 type Work @default.
- W2013984021 sameAs 2013984021 @default.
- W2013984021 citedByCount "62" @default.
- W2013984021 countsByYear W20139840212012 @default.
- W2013984021 countsByYear W20139840212013 @default.
- W2013984021 countsByYear W20139840212014 @default.
- W2013984021 countsByYear W20139840212015 @default.
- W2013984021 countsByYear W20139840212016 @default.
- W2013984021 countsByYear W20139840212017 @default.
- W2013984021 countsByYear W20139840212018 @default.
- W2013984021 countsByYear W20139840212019 @default.